Skip to content

Comparative Efficacy of Concentrated Growth Factor versus Free Gingival Graft in Augmenting Keratinized Mucosa Around Dental Implants in the Posterior Mandible: A Randomized Controlled Clinical Study

Comparative Efficacy of Concentrated Growth Factor versus Free Gingival Graft in Augmenting Keratinized Mucosa Around Dental Implants in the Posterior Mandible: A Randomized Controlled Clinical Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500113271
Enrollment
Unknown
Registered
2025-11-26
Start date
2025-12-01
Completion date
Unknown
Last updated
2025-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tooth defects and tooth loss

Interventions

Intervention Group:Root-oriented reset flap Concentrated growth factors
Control Group:Root coverage flap + free gingival graft

Sponsors

Peking University Shenzhen Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Age>= 18 years, and in good systemic health. 2.Subjects with tooth loss in the posterior mandible scheduled for implant restoration, presenting with buccal keratinized mucosa width (KMW) < 2 mm, and who are indicated for and accept correction via apically positioned flap (APF) vestibuloplasty. 3.The edentulous area is a non-free-end saddle, involving 1 to 3 missing tooth positions. 4.The patient agrees to participate in the study and provides signed informed consent.

Exclusion criteria

Exclusion criteria: 1.Pregnant or lactating women. 2.Subjects where the surgical site cannot avoid the mental foramen. 3.Subjects requiring bone augmentation surgery in the intended implant site. 4.Subjects with a history of mucogingival surgery in the target area (e.g., free gingival graft, connective tissue graft). Subjects who have undergone radiotherapy in the head and neck region. 5.Subjects with systemic diseases affecting healing, such as uncontrolled diabetes (HbA1c > 7.0%), immunodeficiencies, or coagulation disorders. 6.Heavy smokers (smoking > 10 cigarettes per day).

Design outcomes

Primary

MeasureTime frame
Long-term Keratinized Mucosa Width Gain;

Secondary

MeasureTime frame
Periodontal Health (GI & PD);Postoperative Pain (VAS Score);Gingival Healing Index (LHI Score);Keratinized Mucosa Shrinkage Rate;Short-term Keratinized Mucosa Width Gain;Long-term Keratinized Mucosa Thickness;Gingival Aesthetic Score;

Countries

China

Contacts

Public ContactDongyun Wang

Peking University Shenzhen Hospital

1074163143@qq.com+86 755 83923333

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026